tiprankstipranks
INVO Bioscience (INVO)
NASDAQ:INVO
US Market

INVO Bioscience (INVO) Financial Statements

110 Followers

INVO Bioscience Financial Overview

INVO Bioscience's market cap is currently ―. The company's EPS TTM is $-8.66; its P/E ratio is -0.18; INVO Bioscience is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 254.36K$ 297.38K$ 278.14K$ 235.32K$ 146.13K
Gross Profit$ 315.90K$ 275.47K$ 198.95K$ 126.20K$ 67.88K
EBIT$ -2.06M$ 2.97M$ -2.72M$ -2.55M$ -2.80M
EBITDA$ -1.98M$ 3.23M$ -2.71M$ -2.47M$ -2.72M
Net Income Common Stockholders$ -2.24M$ 2.76M$ -2.77M$ -2.55M$ -2.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 112.48K$ 2.19M$ 90.14K$ 285.70K$ 1.96M
Total Assets$ 6.64M$ 6.15M$ 4.10M$ 4.68M$ 6.42M
Total Debt$ 4.10M$ 1.84M$ 2.66M$ 1.96M$ 2.01M
Net Debt$ 3.99M$ -343.46K$ 2.57M$ 1.67M$ 52.01K
Total Liabilities$ 8.34M$ 6.06M$ 5.08M$ 3.39M$ 3.07M
Stockholders Equity$ -1.71M$ 88.47K$ -977.61K$ 1.29M$ 3.36M
Cash Flow-
Free Cash Flow$ -1.91M$ -1.15M$ -1.00M$ -1.65M$ -1.88M
Operating Cash Flow$ -1.64M$ -1.15M$ -1.00M$ -1.65M$ -1.87M
Investing Cash Flow$ -261.50K$ -8.45K$ 8.58K$ -3.01K$ -4.90K
Financing Cash Flow$ -169.86K$ 3.26M$ 800.00K$ -25.20K$ 0.00
Currency in USD

INVO Bioscience Earnings and Revenue History

INVO Bioscience Debt to Assets

INVO Bioscience Cash Flow

INVO Bioscience Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis